Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
It's a foundational step that demands precision
Tremfya (guselkumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $3.67 billion Why it sold so well: J&Js IL-23 inhibitor Tremfya experienced significant sales growth last year with $3.67 billion in total sales, an increase of 16.6% from 2023
Late-onset ornithine transcarbamylase deficiency: a potentially fatal yet treatable cause of coma
How GLP-1 Works in the Brain The discovery of GLP-1s role in addiction is connected to its interaction with the brains reward system , particularly the mesolimbic dopamine pathway, which is involved in the sensation of pleasure and reward
US$ 27.17
US$ 26.86
US$ 24.86
US$ 24.48
